R&D Views & Analysis | pharmaphorum

Views & Analysis

Collaboration likemindedness unity alignment 600

Clinical trials: collaboration is the secret to successful o...

Bringing new products to market in the era of outsourced clinical trials is reliant on the ability of sponsors and CROs to work together.

Views & Analysis

Pharma R&D is crying out for disruption – is AI the answer?

Artificial Intelligence (AI), big data and genomics are coming together to revolutionise drug discovery and development.

Views & Analysis

Science Molecule, Molecular DNA Model Structure, business teamwork conceptMolecular, DNA and atom model in science research labMolecular, DNA and atom model in science research lab setting in studio.

A world leader in genomics, but England’s patients face obst...

England is at the forefront of the genomics revolution – but NHS patients are unlikely to be the first to benefit.

Views & Analysis

Impact of data management on clinical trials: new study

The correlation between the upfront time to build and release a clinical database and its impact on downstream data management.

Views & Analysis

deep_dive_slider images_underpinning RD article

Data: underpinning health R&D

Big data initiatives positioning the UK as a desirable location for R&D.

Debates & Insight

Pricing and market access – facts versus fiction

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

Clinical trials: collaboration is the secret to successful o...

Pharma R&D is crying out for disruption – is AI the answer?

A world leader in genomics, but England’s patients face obst...

Impact of data management on clinical trials: new study

Data: underpinning health R&D

Pricing and market access – facts versus fiction

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks